This is the central regulatory problem that full FDA approval would need to solve and it is the reason PCAC reviews for peptides like BPC-157 often hinge on available safety data rather than efficacy evidence from controlled human studies
This represents a compound annual growth rate (CAGR) of about 7.9% to 8.2% from 2024/25 onward
Al Rajabi A 1 , Castro GS, da Silva RP, Nelson RC, Thiesen A, Vannucchi H, Vine DF, Proctor SD, Field CJ, Curtis JM, Jacobs RL
Your body makes it
Our licensed nurses can administer glutathione via: Intravenous (IV) Drip: A slow infusion of glutathione in a saline solution directly into a vein
Kaufman DW, Kelly JP, Curhan GC, Anderson TE, Dretler SP, Preminger GM, Cave DR